Monthly E-newsletter - May 2021
Newsletter on Pharma advancement
Pharma Advancment news letter subscribe Advertise with us
May - 2021Ι Volume 5 I Pharma Advancement E-newsletter
Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Latest Updates
Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine in the Indian Market.
Dr. Reddy’s Laboratories Ltd announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1stMay, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on 13th May, 2021. As part of a limited pilot, the soft launch...
Pfizer & BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine Facility
India authorises DRDO's oxygen dependence-lowering drug for Covid-19
Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19
Vectura and Inspira Pharma Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
FDA Grants FTD to CERC-002 for Treatment of Hospitalized Patients with COVID-19
Advertise in Our Next Issue - Contact
FedEx Extends Support and Donates Second Charter Flight to Deliver Critical Aid to India

FedEx Express, a subsidiary of FedEx Corp announced the arrival of a second dedicated charter flight carrying critical ..

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

Rentschler Biopharma and Vetter, two globally operating CDMOs, announced that their strategic collaboration has taken key steps forward...

Russia authorises use of single dose Covid-19 vaccine Sputnik Light

The Gamaleya National Research Center of Epidemiology and Microbiology and the RDIF have announced the Russian Ministry of Health's authorisation...

Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell & Gene Clinical Trial

LabConnect and Cryoport announced a partnership to provide comprehensive logistics support for an upcoming Phase...

Bharat Biotech's Covaxin approved for phase 2/3 trials on children

The Drugs Controller of India has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between 2 to 18 Yrs.

View All Press Releases
Popular Events
CPhI China 2021
2021-12-16 - 2021-12-18
SNIEC , China
Digital Pathology & AI Congress USA
2021-09-02 - 2021-09-03
New York, USA
API China 2021
2021-05-26 - 2021-05-28
China Import and Export Complex, China
BePharma 2021
2021-09-06 - 2021-09-08
Hilton Mexico City Reforma , Mexico

Editorial Inquiries

Advertising Inquiries